바이오테 (BTMD) 주가

바이오테(BTMD)는 NASDAQ에 상장된 Healthcare · Medical Care Facilities 기업입니다. 현재가 $1.47 (-1.34%), 시가총액 $0.07B, PER 4.66, 52주 범위 $1.30 ~ $4.55.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other adminis

핵심 지표

• 현재가: $1.47 (-1.34%)
• 시가총액: $0.07B
• PER (주가수익비율): 4.66
• 52주 최저~최고: $1.30 ~ $4.55
• 섹터: Healthcare
• 산업: Medical Care Facilities
• 거래소: NASDAQ

바이오테의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

바이오테 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.8333

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.96
• 순이익률: 0.08%
• 영업이익률: 0.10%

자주 묻는 질문